| Predicate |
Object |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-28 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-00 |
| filingDate |
2003-03-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c644c075f0031e44095de24fdf6e3fb9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_34ebb9cd5878b69d8a71186cb1806333
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_71979d67a090d93ac0e40d365c9b6097 |
| publicationDate |
2003-12-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2003224973-A1 |
| titleOfInvention |
Minimising body gain in insulin treatment |
| abstract |
A method for minimising weight gain, preventing weight gain or inducing weight loss in a mammal, said method involving a treatment regimen which comprises administration of an insulin derivative having a substituent containing from 6 to 40 carbon atoms attached to one of its amino acid residues. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2019169257-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8003605-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7387996-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004006000-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10815287-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004038864-A1 |
| priorityDate |
2002-03-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |